Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual General Meeting (AGM) of Autolus Therapeutics Plc held on June 29, 2026. The filing details the voting results for six resolutions submitted to shareholders, including the adoption of the 2025 Annual Report and Accounts, auditor appointment, and director re-elections.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. The document confirms that shareholders voted to adopt the accounts for the financial year ended December 31, 2025, but the numerical data contained within those accounts is not included in this report.
Material Changes and Voting Results
All six resolutions submitted at the AGM were passed. The voting breakdown for each resolution is as follows:
- Resolution 1 (Adoption of 2025 Accounts): 165,846,326 For; 2,895,344 Against; 75,901 Abstain.
- Resolution 2 (Directors' Remuneration Report): 156,192,216 For; 12,502,946 Against; 122,409 Abstain.
- Resolution 3 (Auditor Appointment - Ernst & Young LLP): 165,871,368 For; 2,872,225 Against; 73,978 Abstain.
- Resolution 4 (Re-election of Mr. M Bonney): 165,491,394 For; 3,312,126 Against; 14,051 Abstain.
- Resolution 5 (Re-election of Dr. E Leiderman): 165,741,204 For; 3,063,838 Against; 12,529 Abstain.
- Resolution 6 (Re-election of Mr. RW Azelby): 162,133,091 For; 6,671,776 Against; 12,704 Abstain.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It references a definitive proxy statement filed on June 5, 2026, for further details on the resolutions.
Investor Verification Checklist
- Review the 2025 Annual Report and Accounts to verify the financial performance figures referenced in Resolution 1.
- Examine the definitive proxy statement filed on June 5, 2026, for detailed context on the Directors' remuneration report (Resolution 2).
- Confirm the re-election of the three directors (Bonney, Leiderman, Azelby) and their respective voting support levels.
- Verify the appointment of Ernst & Young LLP (US) as the independent auditor for the 2026-2027 term.